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Abstract
Background-In addition to the acute fall in carbon monoxide transfer factor (TLCo) associated with Pneumocystis carinii pneumonia (PCP) There was no significant difference in the number of smokers (n = 43) and non-smok- 
Discussion
Abnormalities of pulmonary function tests are common in patients with HIV-I infection."3 Reduction in TLco is associated both with PCP and other acute pulmonary diseases,2 but occurs also in HIV-I infected individuals without obvious clinical lung disease."2 The mechanism for reduced TLCo in HIV-I infection in the absence of overt pulmonary disease is not understood, but does not seem to be due to HIV-I mediated alveolitis, as previously proposed,9 nor is it related to the presence of HIV-I in lung macrophages.9 15 When a reduction in TLCO heralds the development of PCP, this reduction is due predominantly to a fall in the membrane diffusion capacity (DM) component of TLco. This has been attributed to thickening of the diffusion pathway between alveolar gas and pulmonary capillary blood by the attachment of Pneumocystis trophozoites to the epithelial surface-the so-called "alveolar capillary block".5 This is in contrast to the chronic reduction in TLCO seen in HIV seropositive individuals who have no evidence of acute or active pulmonary disease. In this case the reduction in TLco is related to the combination of reduced DM and a reduction in pulmonary capillary blood volume (Vc). 12 By reflecting this lung injury, a reduced TLCO may act as a marker of more advanced HIV-I infection. This concept is supported by the previously observed fall in TLco with advancing immunosuppression,3 and would explain the power of TLCO measurement in predicting those patients at greater risk of a faster progression to AIDS. Since the Kco did not predict the development of AIDS, it would imply that loss of lung volume-that is, the area available for gas exchange-is the major determinant of the predictive capacity of TLCO.
We have shown, therefore, that a reduced TLCO in HIV-I infection, before an AIDS diagnosis, identifies a group of patients who progress more rapidly to AIDS. This reduction in TLCO during HIV-I infection may represent subtle lung inflammation associated with increasing immunosupression, pathophysiologically different from the acute fall in TLCO during PCP as a result of alveolar capillary block. Further investigation of the potential of TLCO as a surrogate marker of advancing immunosuppression in HIV-I infection is required. Since therapeutic decision making in HIV-I infection (such as when to start zidovudine treatment or chemoprophylaxis for PCP) is commonly made on the basis of deteriorating immunocompetence,23 24 the clinical usefulness of TLCO in predicting a more rapid development of AIDS should be compared with established indices of disease progression such as CD4 + cell count and P24 antigenaemia.25
